Third-generation taxanes SB-T-121605 and SB-T-121606 are effective in pancreatic ductal adenocarcinoma.

Pancreatic cancer is a severe malignancy with increasing incidence and high mortality due to late diagnosis and low sensitivity to treatments. Search for the most appropriate drugs and therapeutic regimens is the most promising way to improve the treatment outcomes of the patients. This study aimed to compare (1) in vitro efficacy and (2) in vivo antitumor effects of conventional paclitaxel and the newly synthesized second (SB-T-1216) and third (SB-T-121605 and SB-T-121606) generation taxanes in KRAS wild type BxPC-3 and more aggressive KRAS G12V mutated Paca-44 pancreatic cancer cell line models. In vitro, paclitaxel efficacy was 27.6 ± 1.7 nM, while SB-Ts showed 1.7-7.4 times higher efficacy. Incorporation of SB-T-121605 and SB-T-121606 into in vivo therapeutic regimens containing paclitaxel was effective in suppressing tumor growth in Paca-44 tumor-bearing mice at small doses (≤3 mg/kg). SB-T-121605 and SB-T-121606 in combination with paclitaxel are promising candidates for the next phase of preclinical testing.

Degradation of ammonia from gas stream by advanced oxidation processes.

The reduction of ammonia emissions from air was experimentally investigated by advanced oxidation processes (AOPs) utilizing the combination of ultraviolet irradiation with ozone. The influence of operating conditions such as initial ammonia concentration and flow rate of gas on the reduction of ammonia concentration was investigated in homemade photochemical unit. The conversion of ammonia decreased with increasing initial concentration of ammonia and with increasing flow rate of air (decreasing retention time). The highest conversion of ammonia (97%) was achieved under lower initial concentration of ammonia (30 ppm) and lower flow rate of air (28 m3/h). The energy per order was evaluated for the advanced oxidation process too. The energy consumption was about 0.037 kWh/m3/order for the 97% ammonia conversion at 30 ppm of initial ammonia concentration and 28 m3/h flow rate of air. Based on the results, the advanced oxidation process combining the UV irradiation and ozone was effective for mitigation of ammonia concentration and presents a promising technology for the reduction of odor emissions from livestock buildings. Moreover, the AOPs are suitable for application for high flow rate of air, especially for ammonia abatement from livestock buildings, where very high efficiency is expected.

Understanding regeneration through proteomics.

Regeneration is a complex cellular process that, rather than simply forming a scar following injury, the animal forms a new functional tissue. Regeneration is a widespread process among metazoa, although not uniformly. Planaria, starfish, and some worms can regenerate most of their body, whereas many other species can only regenerate parts of specific tissues or fail to accomplish a functional regrowth, as is the case of mammals CNS. Research in regenerative medicine will possibly culminate in the regeneration of organs/tissues originally not prone to this process. Despite the complexity of the interactions and regulatory systems involved, the variety of tissues and organs these cells differentiate into has so far impaired the success of direct transplantation to restore damaged tissues. For this reason, a study, at the molecular level of the regeneration mechanisms developed by different animal models is likely to provide answers to why these processes are not readily activated in mammals. Proteomic-based approaches are being recognized as extremely useful to study of regeneration events, also because there is a relevant contribution of posttranscriptional processes that involve frequently the occurrence of a broad range of PTMs. The present review focuses on the significant knowledge brought up by proteomics in diverse aspects of regeneration research on different animal models, tissues, and organs.